Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory. Stallard, N. Biometrics, 54:279-294, 1998. bibtex @article{sta98sam,
title = {Sample Size Determination for Phase {{II}} Clinical Trials Based on {{Bayesian}} Decision Theory},
volume = {54},
journal = {Biometrics},
author = {Stallard, Nigel},
year = {1998},
keywords = {sample-size,bayesian-inference,rct,study-design,group-sequential,backwards-induction,cost-benefit-analysis,gain-function-used-to-consider-costs-of-drug-development,multistage-design,optimal-stopping},
pages = {279-294},
citeulike-article-id = {13264902},
posted-at = {2014-07-14 14:09:45},
priority = {0}
}
Downloads: 0
{"_id":"cioXzP2CWC5NYMW89","bibbaseid":"stallard-samplesizedeterminationforphaseiiclinicaltrialsbasedonbayesiandecisiontheory-1998","downloads":0,"creationDate":"2018-06-23T20:06:36.114Z","title":"Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory","author_short":["Stallard, N."],"year":1998,"bibtype":"article","biburl":"http://hbiostat.org/bib/harrelfe.bib","bibdata":{"bibtype":"article","type":"article","title":"Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory","volume":"54","journal":"Biometrics","author":[{"propositions":[],"lastnames":["Stallard"],"firstnames":["Nigel"],"suffixes":[]}],"year":"1998","keywords":"sample-size,bayesian-inference,rct,study-design,group-sequential,backwards-induction,cost-benefit-analysis,gain-function-used-to-consider-costs-of-drug-development,multistage-design,optimal-stopping","pages":"279-294","citeulike-article-id":"13264902","posted-at":"2014-07-14 14:09:45","priority":"0","bibtex":"@article{sta98sam,\n title = {Sample Size Determination for Phase {{II}} Clinical Trials Based on {{Bayesian}} Decision Theory},\n volume = {54},\n journal = {Biometrics},\n author = {Stallard, Nigel},\n year = {1998},\n keywords = {sample-size,bayesian-inference,rct,study-design,group-sequential,backwards-induction,cost-benefit-analysis,gain-function-used-to-consider-costs-of-drug-development,multistage-design,optimal-stopping},\n pages = {279-294},\n citeulike-article-id = {13264902},\n posted-at = {2014-07-14 14:09:45},\n priority = {0}\n}\n\n","author_short":["Stallard, N."],"key":"sta98sam","id":"sta98sam","bibbaseid":"stallard-samplesizedeterminationforphaseiiclinicaltrialsbasedonbayesiandecisiontheory-1998","role":"author","urls":{},"keyword":["sample-size","bayesian-inference","rct","study-design","group-sequential","backwards-induction","cost-benefit-analysis","gain-function-used-to-consider-costs-of-drug-development","multistage-design","optimal-stopping"],"downloads":0},"search_terms":["sample","size","determination","phase","clinical","trials","based","bayesian","decision","theory","stallard"],"keywords":["backwards-induction","bayesian-inference","cost-benefit-analysis","gain-function-used-to-consider-costs-of-drug-development","group-sequential","multistage-design","optimal-stopping","rct","sample-size","study-design","*import"],"authorIDs":[],"dataSources":["mEQakjn8ggpMsnGJi"]}